Mid-cap Picks with Anil Singhvi: CDSL, Strides Pharma and Metropolis Lab, 3 stocks Ashish Kukreja picked for great gains
Markets have built up a strong momentum with today being another good day for investors. However, a number of uncertainties still have big negative potential. In this situation, market expert Ashish Kukreja has revealed, in a chat with Zee Business Managing Editor Anil Singhvi, that he is quite bullish on the Financial Services sector
Markets have built up a strong momentum with today being another good day for investors. However, a number of uncertainties still have big negative potential. In this situation, market expert Ashish Kukreja has revealed, in a chat with Zee Business Managing Editor Anil Singhvi, that he is quite bullish on the Financial Services sector particularly on certain stocks that he identified in the mid-cap space. What are these top stock picks of his? Well, read on to profit - these are with a positional medium term view and short term view.
Top Stocks To Buy: Central Depository Services (India) Ltd
Market analyst Kukreja once again picked a stock from the retail broking sector as his long term buy. Today, he picked Central Depository Services (CDSL) stock. He said that the financial services sector is witnessing a big shift and retail participation is only growing. He recommended buying in the stock at the current levels of Rs 324. The company has a sizeable presence in the small investor segment. It is a quality stock at these levels, he said. It may see levels between Rs 400 and Rs 450 in the next one year, he said.
He had earlier suggested investment in Motilal Oswal.
Watch Zee Business Tweet Video Below:
#SPLMidcapStocks | शॉर्ट टर्म, पोजीशनल और लॉन्ग टर्म में शानदार रिटर्न के लिए क्राफ्ट वेल्थ मैनेजमेंट के MD आशीष कुकरेजा के मजबूत फंडामेंटल वाले 3 बेहतरीन मिडकैप स्टॉक्स#ZBizBazaar #Midcap #MidcapStocks @AnilSinghvi_ @Ashishmuse pic.twitter.com/j80lkJL6YN
— Zee Business (@ZeeBusiness) July 23, 2020
Top Stocks To Buy: Strides Pharma
The technical analyst picked his positional medium term stock from the pharma sector. Kukreja said that Strides Pharma valuations are quite attractive despite an existing situation of discomfort in the pharma segment. The company has a firm exposure in emerging and developed markets. The stock is currently trading at around Rs 418. The volumes may see an uptick by 3-4 times in next 2-3 years. It is available at discounted valuation and will see a rise, going forward. It has the potential to achieve levels between Rs 475 and Rs 500 on an immediate basis, he said.
See Zee Business Live TV Streaming Below:
Top Stocks To Buy: Metropolis Lab
As for short term, the analyst picked Metropolis Lab – a stock in the diagnostics sector. The stock is currently trading around Rs 1484. Its shares are currently available at discounted rates and this sector will do quite well too. The share price may rise up to Rs 1700 over the next 3-4 months, he said.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
EPFO Pension Schemes: Early pension, retirement pension, nominee pension and 4 other pension schemes that every private sector employee should know
Tata Motors, Muthoot Finance and 3 more: Axis Direct recommends buying these stocks for 2 weeks; check targets, stop losses
09:06 PM IST